Observational × Squamous Cell Carcinoma of Head and Neck × Clear all The Role of Circulating Tumour DNA in Head and Neck Cancer
Recruiting
250 enrolled
SPAR
Not yet recruiting
120 enrolled
DoIT_Neck
Recruiting
250 enrolled
CTCO
Completed
12 enrolled
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Recruiting
500 enrolled
PREDAPT-HNSCC2
Withdrawn
MicroRNA Markers in Head and Neck Cancers
Active not recruiting
225 enrolled
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
Recruiting
30 enrolled
POLARIS
Not yet recruiting
180 enrolled
MOSES
Active not recruiting
100 enrolled
HN-ORAL-RT
Active not recruiting
100 enrolled
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
Recruiting
410 enrolled
DECT-CEco
Recruiting
30 enrolled
Collagen Matrix in Oral Cancer Surgery
Completed
33 enrolled
MASST
Active not recruiting
39 enrolled
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
Completed
78 enrolled
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Completed
135 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Recruiting
250 enrolled
Clear-HPVca
Completed
103 enrolled
NEUTROFLOW
Not yet recruiting
600 enrolled
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Active not recruiting
200 enrolled
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Recruiting
8,000 enrolled
The Head and Neck Tumor Biobank
Completed
419 enrolled
ST-ICI02
Recruiting
200 enrolled
Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Completed
662 enrolled
PDO Based Drug Sensitive Test in R/M HNSCC
Recruiting
100 enrolled
ORACLE
Recruiting
2,020 enrolled
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
Recruiting
35 enrolled
Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer
Recruiting
500 enrolled
Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma
Not yet recruiting
25 enrolled
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Withdrawn
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Recruiting
170 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Active not recruiting
150 enrolled
Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab
Completed
31 enrolled
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Recruiting
144 enrolled
Radiomics Model for Assessing Lymph Node Status in cN0 Patients withHNSCC
Completed
700 enrolled
SYMILIS OCT
Recruiting
200 enrolled
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC
Completed
25 enrolled
MRD-DUCHESS
Recruiting
75 enrolled
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
Completed
130 enrolled
Serpentine
Recruiting
1,000 enrolled
Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
Terminated
8 enrolled 5 charts
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Recruiting
220 enrolled
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Not yet recruiting
55 enrolled
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active not recruiting
15 enrolled
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
Recruiting
128 enrolled
SENIOR
Recruiting
1,500 enrolled
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
Completed
225 enrolled